Editorial: Hormone resistance in cancer

por Phoenix, John T., Budreika, Audris, Kostlan, Raymond J., Hwang, Justin H., Fanning, Sean W., Kregel, Steven
Publicado 2023

1567. Perspectives of People with HIV (PWH) 6 Months Following a Switch to Cabotegravir and Rilpivirine Long-acting (CAB+RPV LA) in an Observational Real-world US Study (BEYOND)

por Dandachi, Dima, Cunningham, Douglas, Valenti, William M, Phoenix, John, Nguyen, Kaitlin, Teichner, Paula, Jean-Louis, Ashley, Reynolds, Maria, Richardson, David, Garris, Cindy
Publicado 2023

1288. Bone Safety Outcomes with F/TAF vs. F/TDF for PrEP in the DISCOVER Trial

por Wohl, David, Ruane, Peter, Hosek, Sybil, Creticos, Catherine, Morris, Sheldon, Phoenix, John, Ramgopal, Moti, Brinson, Cynthia, Tremblay, Cecile, Carter, Christoph C, Wong, Pamela, Brainard, Diana M, McCallister, Scott, Das, Moupali, Thompson, Melanie A
Publicado 2019

Clinically relevant humanized mouse models of metastatic prostate cancer to evaluate cancer therapies

por Kostlan, Raymond J., Phoenix, John T., Budreika, Audris, Ferrari, Marina G., Khurana, Neetika, Cho, Jae Eun, Juckette, Kristin, McCollum, Brooke L., Moskal, Russell, Mannan, Rahul, Qiao, Yuanyuan, Griend, Donald J. Vander, Chinnaiyan, Arul M., Kregel, Steven
Publicado 2023

1547. Integrating Long-acting Injectable Cabotegravir for PrEP into Standard of Care for Cisgender Women, Transgender Women, Transgender Men, and Men Who Have Sex with Men: Results...

por Valenti, William M, Phoenix, John, Patel, Rupa R, Tims-Cook, Zandraetta, Pilgrim, Nanlesta, Haley, Amber, Sutton, Kenneth, Gaudion, Alison, Merrill, Deanna, Urbaityte, Rimgaile, Li, Bo, Andrae, David, Bonner, Courtney, Herbst, Abigail, Chowdhury, Dhuly, Garges, Harmony, Czarnogorski, Maggie
Publicado 2023